HPHA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Heidelberg Pharma AG

Watchlist Manager

Watchlist

Price: 2.75 EUR 0.73%

Market Cap: €128.6m

	Heidelberg Pharma AG XETRA:HPHA	DE
S	Sankyu Inc TSE:9065	JP
	Southern Copper Corp NYSE:SCCO	US
	UBE Corp TSE:4208	JP
	E ON SE MIL:EOAN	DE
	MTU Aero Engines AG XETRA:MTX	DE
	China Minsheng Banking Corp Ltd SSE:600016	CN
I	Intchains Group Ltd NASDAQ:ICG	CN
	Toyota Motor Corp TSE:7203	JP
	Stellantis NV MIL:STLAM	NL
M	Myriad Genetics Inc XHAM:MYD	US
	Deep Yellow Ltd OTC:DYLLF	AU
	Volkswagen AG XETRA:VOW	DE

Profitability Summary

Heidelberg Pharma AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

77%

Gross Margin is Increasing

72% > 81%

Negative Operating Margin

-3.145%

Negative 3Y Average Operating Margin

-600%

Declining Operating Margin

-84% > -3.145%

Negative Net Margin

-2.901%

Negative 3Y Average Net Margin

-560%

Declining Net Margin

-96% > -2.901%

Negative Free Cash Flow Margin

-2.178%

Negative 3Y Average Free Cash Flow Margin

-623%

Declining Free Cash Flow Margin

-70% > -2.178%

Negative ROE

-424%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-120%

Declining ROIC

-108% > -225%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.